Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats

ConclusionOur findings demonstrated that CLSTN1 promotes the pathogenesis of doxorubicin-induced DCM. CLSTN1 could be a therapeutic target to prevent the development of doxorubicin-induced DCM.

http://link.springer.com/10.1007/s10557-022-07389-x

Source: Cardiovascular Drugs and Therapy - November 9, 2022 Category: Cardiology Source Type: research